MY127212A - New pyridine-substituted pyrazolopyridine derivatives - Google Patents

New pyridine-substituted pyrazolopyridine derivatives

Info

Publication number
MY127212A
MY127212A MYPI20015302A MYPI20015302A MY127212A MY 127212 A MY127212 A MY 127212A MY PI20015302 A MYPI20015302 A MY PI20015302A MY PI20015302 A MYPI20015302 A MY PI20015302A MY 127212 A MY127212 A MY 127212A
Authority
MY
Malaysia
Prior art keywords
pyrazolopyridine derivatives
new pyridine
disorders
substituted pyrazolopyridine
treatment
Prior art date
Application number
MYPI20015302A
Other languages
English (en)
Inventor
Johannes-Peter Stasch Dr
Elisabeth Perzborn Dr
Alexander Straub Dr
Achim Feurer Dr
Cristina Alonso-Alija Dr
Elke Stahl Dr
Klaus Dembowsky Dr
Dietmar Flubacher Dr
Frank Wunder Dr
Stefan Weigand Dr
Dieter Lang Dr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MY127212A publication Critical patent/MY127212A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
MYPI20015302A 2000-11-22 2001-11-20 New pyridine-substituted pyrazolopyridine derivatives MY127212A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10057753 2000-11-22
DE10131987A DE10131987A1 (de) 2000-11-22 2001-07-02 Neue Pyridin-substituierte Pyrazolopyridinderivate

Publications (1)

Publication Number Publication Date
MY127212A true MY127212A (en) 2006-11-30

Family

ID=7664122

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20015302A MY127212A (en) 2000-11-22 2001-11-20 New pyridine-substituted pyrazolopyridine derivatives

Country Status (12)

Country Link
KR (1) KR20030065519A (de)
DE (2) DE10131987A1 (de)
DO (1) DOP2001000291A (de)
EC (1) ECSP034616A (de)
GT (1) GT200100235A (de)
HN (1) HN2001000261A (de)
MY (1) MY127212A (de)
PE (1) PE20020581A1 (de)
RU (1) RU2003118584A (de)
SV (1) SV2003000743A (de)
UA (1) UA74404C2 (de)
ZA (1) ZA200303887B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102485724B (zh) * 2010-12-06 2015-08-12 中国人民解放军军事医学科学院毒物药物研究所 取代噻吩基吡唑并吡啶类化合物及其医药用途
WO2013076168A1 (de) 2011-11-25 2013-05-30 Bayer Pharma Aktiengesellschaft Verfahren zur herstellung von substituierten 5-fluor-1h-pyrazolopyridinen
WO2018069126A1 (de) * 2016-10-11 2018-04-19 Bayer Pharma Aktiengesellschaft Kombination enthaltend sgc stimulatoren und mineralocorticoid-rezeptor-antagonisten

Also Published As

Publication number Publication date
GT200100235A (es) 2002-06-25
DE10131987A1 (de) 2002-05-23
KR20030065519A (ko) 2003-08-06
RU2003118584A (ru) 2004-12-20
ZA200303887B (en) 2004-06-21
PE20020581A1 (es) 2002-07-13
ECSP034616A (es) 2003-06-25
DOP2001000291A (es) 2002-12-15
UA74404C2 (uk) 2005-12-15
SV2003000743A (es) 2003-01-13
HN2001000261A (es) 2002-01-30
DE50106655D1 (de) 2005-08-04

Similar Documents

Publication Publication Date Title
MXPA03004500A (es) Nuevos derivados de pirazolopiridina sustituidos con piridina.
EP1248612A4 (de) Neue substanzen und verbindungen als protease-inhibitoren
MX2007007220A (es) Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos.
UA74419C2 (uk) Заміщені піридини та їх застосування як антагоністів рецептору метаботропного глутамату
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
HK1066810A1 (en) Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
MXPA05002442A (es) Imidazolopiridinas y metodos para la elaboracion y uso de las mismas.
GB0504828D0 (en) Therapeutic agents
AU2003221536A1 (en) Use of stimulators of soluble guanylate cyclase for treating glaucoma
AU2003229772A1 (en) Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
RS20050200A (en) Pyrazolopyridines and methods of making and using the same
MXPA03009750A (es) Compuestos quimicos.
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
WO2004022528A3 (en) Arylglycine derivatives and their use as glycine transport inhibitors
MXPA03005601A (es) Nuevos compuestos y composiciones como inhibidores de catepsina.
IL151646A0 (en) Use of pyrido[3,2-e]-pyrazinones as inhibitors of phosphodicesterase 5 for treating erectile dysfunction
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
MXPA02009549A (es) Imidazopiridinas triciclicas.
MY127212A (en) New pyridine-substituted pyrazolopyridine derivatives
MXPA04003544A (es) Benzotriazepinas como ligandos del receptor de gastrina y colecistocinina.
HK1072935A1 (en) Condensed camptothecins as antitumor agents
AR027134A1 (es) Derivados de indol.
ATE298742T1 (de) Zykloalkenylsulfonamidderivate
YU73200A (sh) 2-aminopiridini koji sadrže spojene ciklične supstituente kao inhibitori nitro oksid sintaze
TH62974A (th) อนุพันธ์ไพราโซโลไพริดีนตัวใหม่ที่ถูกแทนที่ด้วยไพริดีน